96
Vaginal Flora, Co-infections and Immune Cells in the Genital Mucosa: Implications for HIV Transmission
Rupert Kaul
Univ of Toronto, Canada
Background: The average probability of acquiring HIV
during a single unprotected sex act is surprisingly low, but tremendous
heterogeneity contributes to the ongoing pandemic. Common mucosal
co-infections, including Herpes simplex type 2 (HSV-2) and bacterial
vaginosis, may increase HIV susceptibility. Analogous heterogeneity in HIV
disease progression and secondary transmission has been described as a “numbers
game,” with the important predictive number being the HIV viral load in the
blood and genital secretions, respectively. Work from our group suggests that
heterogeneity in susceptibility may also be predictable, with the number of HIV
target cells in the genital mucosa being the important determinant of outcome
after unprotected HIV exposure.
Methods: Studies enrolled HIV at-risk and infected
participants from Canada and Kenya, and examined the associations of common
genital co-infections with alterations in mucosal immunity and HIV
transmission. Laboratory parameters studied have included co-infection
diagnostics, cytokine /chemokine levels, immune gene expression levels, and
flow cytometry-based elucidation of immune cell populations.
Results: HIV acquisition was strongly associated
with prevalent HSV-2 infection and “classical” sexually transmitted infections.
All co-infections were associated with significant increases in cervical HIV
target cells, including activated CD4+ T cells and DC-SIGN+
dendritic cells. Alterations in vaginal flora—both bacterial vaginosis and
intermediate flora—had similar effects in HIV-susceptible women, and in
HIV-infected women were associated with reversible increases in HIV shedding
and alterations in mucosal immune cell populations.
Conclusions: We conclude that a variety of genital
co-infections appears to enhance HIV susceptibility (and secondary
transmission), and a common pathway for this effect—as well as for potential
increases in HIV susceptibility associated with candidate vaginal
microbicides—may be the local recruitment of activated mucosal immune cells. HSV-2
infection and alterations in vaginal flora, due to their high population
prevalence and chronic persistence, may be particularly important drivers of
HIV transmission.
|